Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation… Read more
Market Cap & Net Worth: Stratec SE (STSEY)
Stratec SE (PINK:STSEY) has a market capitalization of $407.22 Million ($407.22 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #21378 globally and #7671 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Stratec SE's stock price $6.70 by its total outstanding shares 60779710 (60.78 Million).
Stratec SE Market Cap History: 2020 to 2025
Stratec SE's market capitalization history from 2020 to 2025. Data shows change from $1.14 Billion to $407.22 Million (-18.84% CAGR).
Stratec SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Stratec SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.58x
Stratec SE's market cap is 1.58 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
25.42x
Stratec SE's market cap is 25.42 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.14 Billion | $250.10 Million | $25.18 Million | 4.57x | 45.40x |
| 2021 | $1.56 Billion | $287.33 Million | $39.96 Million | 5.44x | 39.13x |
| 2022 | $1.58 Billion | $274.62 Million | $29.22 Million | 5.74x | 53.92x |
| 2023 | $1.59 Billion | $261.91 Million | $13.07 Million | 6.06x | 121.55x |
| 2024 | $407.22 Million | $257.62 Million | $16.02 Million | 1.58x | 25.42x |
Competitor Companies of STSEY by Market Capitalization
Companies near Stratec SE in the global market cap rankings as of March 19, 2026.
Key companies related to Stratec SE by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Stratec SE Historical Marketcap From 2020 to 2025
Between 2020 and today, Stratec SE's market cap moved from $1.14 Billion to $ 407.22 Million, with a yearly change of -18.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $407.22 Million | 0.00% |
| 2024 | $407.22 Million | -74.36% |
| 2023 | $1.59 Billion | +0.80% |
| 2022 | $1.58 Billion | +0.78% |
| 2021 | $1.56 Billion | +36.81% |
| 2020 | $1.14 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Stratec SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $407.22 Million USD |
| MoneyControl | $407.22 Million USD |
| MarketWatch | $407.22 Million USD |
| marketcap.company | $407.22 Million USD |
| Reuters | $407.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.